Literature DB >> 27076946

Subcostal thoracoscopic extended thymectomy for patients with myasthenia gravis.

Yong Tang1, Zhu-An Ou1, Ming Liao1, Yiwen Xuan1, Kai Su1, En-Wu Xu1, Haiping Xiao1, Xiufan Peng1, Zhuohua Zhang1, Yan Liu1, Gui-Bin Qiao1.   

Abstract

BACKGROUND: Extended thymectomy is indicated for patients with myasthenia gravis (MG) when drug-resistance or dependence is seen. We have employed a technique for subcostal thoracoscopic extended thymectomy (STET) on patients with MG.
METHODS: Clinical data of 15 eligible patients who underwent STET in our department from February 2015 to November 2015 by the same surgical team were retrospectively analyzed. The operation time, blood loss, duration of postoperative hospital stay, thoracic drainage periods were concerned.
RESULTS: All the surgeries were finished successfully without conversion to sternotomy. Mean operation time was 157.53±40.31 min (range, 73-275 min). Mean blood loss was 56.33±7.07 mL (range, 10-200 mL). Mean pleural drainage volume in the first 24 hours was 72.67±17.68 mL (range, 0-250 mL). Mean postoperative thoracic drainage periods were 1.20±0.71 days (range, 0-3 days). Mean duration of postoperative hospital stay was 6.13±0.71 days (range, 3-22 days).
CONCLUSIONS: This procedure showed satisfactory results for patients with MG. Moreover, the STET approach is more easily for surgeons to fully reveal the bilateral phrenic nerve and the upper thymic poles. We believe that STET is a satisfactory procedure for performing extended thymectomy in well selected patients.

Entities:  

Keywords:  Subcostal; thoracoscopy/video-assisted thoracic surgery (VATS); thymectomy

Year:  2016        PMID: 27076946      PMCID: PMC4805844          DOI: 10.21037/jtd.2016.02.77

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  7 in total

1.  Single-port thymectomy through an infrasternal approach.

Authors:  Takashi Suda; Hiroshi Sugimura; Daisuke Tochii; Mariko Kihara; Yoshinobu Hattori
Journal:  Ann Thorac Surg       Date:  2012-01       Impact factor: 4.330

2.  Subxiphoid uniportal thoracoscopic extended thymectomy.

Authors:  Liang Wu; Lei Lin; Ming Liu; Lei Jiang; Gening Jiang
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

3.  Subxiphoid approach for video-assisted thoracoscopic extended thymectomy in treating myasthenia gravis.

Authors:  Chung-Ping Hsu; Cheng-Yen Chuang; Nan-Yung Hsu; Sen-Ei Shia
Journal:  Interact Cardiovasc Thorac Surg       Date:  2002-09

4.  MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED.

Authors:  A Blalock; M F Mason; H J Morgan; S S Riven
Journal:  Ann Surg       Date:  1939-10       Impact factor: 12.969

5.  Efficacy and safety of artificial pneumothorax under two-lung ventilation in thoracoscopic esophagectomy for esophageal cancer in the prone position.

Authors:  Daisuke Saikawa; Shunichi Okushiba; Masaya Kawata; Tetsuyuki Okubo; Shuji Kitashiro; Yo Kawarada; Yoshinori Suzuki; Hiroyuki Kato
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-10-31

6.  Uniportal bilateral video-assisted thoracoscopic extended thymectomy for myasthenia gravis: A case report.

Authors:  Francesco Paolo Caronia; Alfonso Fiorelli; Mario Santini; Salvatore Cottone
Journal:  J Thorac Cardiovasc Surg       Date:  2015-04-09       Impact factor: 5.209

7.  Video-assisted thoracoscopic thymectomy versus subxiphoid single-port thymectomy: initial results†.

Authors:  Takashi Suda; Ayumi Hachimaru; Daisuke Tochii; Ryo Maeda; Sachiko Tochii; Yasushi Takagi
Journal:  Eur J Cardiothorac Surg       Date:  2015-10-14       Impact factor: 4.191

  7 in total
  2 in total

1.  Definitions and standard indications of minimally-invasive techniques in thymic surgery.

Authors:  Marcin Zieliński
Journal:  J Vis Surg       Date:  2017-08-21

2.  Feasible and promising modified trans-subxiphoid thoracoscopic extended thymectomy for patients with myasthenia gravis.

Authors:  Kazu Shiomi; Eiji Kitamura; Mototsugu Ono; Yasuto Kondo; Masahito Naito; Masashi Mikubo; Yoshio Matsui; Kazutoshi Nishiyama; Takashi Suda; Yukitoshi Satoh
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.